Compile Data Set for Download or QSAR
Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 12665
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718864(US20250042904, Compound 58)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718854(US20250042904, Compound 44)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718855(US20250042904, Compound 45)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718856(US20250042904, Compound 46)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718857(US20250042904, Compound 47)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718858(US20250042904, Compound 48)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718859(US20250042904, Compound 49)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718860(US20250042904, Compound 50)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718861(US20250042904, Compound 51)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718862(US20250042904, Compound 52)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718863(US20250042904, Compound 57)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718853(US20250042904, Compound 43)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718865(US20250042904, Compound 59)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718866(US20250042904, Compound 60)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718867(US20250042904, Compound 61)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718868(US20250042904, Compound 62)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718869(US20250042904, Compound 63)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718870(US20250042904, Compound 64)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718871(US20250042904, Compound 65)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718872(US20250042904, Compound 68)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718873(US20250042904, Compound 69)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718874(US20250042904, Compound 70)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718842(US20250042904, Compound 14)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718832(US20250042904, Compound 2)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718833(US20250042904, Compound 3)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718834(US20250042904, Compound 4)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718835(US20250042904, Compound 5)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718836(US20250042904, Compound 6)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718837(US20250042904, Compound 7)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718840(US20250042904, Compound 12)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718831(US20250042904, Compound 1)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718847(US20250042904, Compound 36)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718848(US20250042904, Compound 37)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718849(US20250042904, Compound 38)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718850(US20250042904, Compound 39)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718851(US20250042904, Compound 41)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718852(US20250042904, Compound 42)
Affinity DataIC50: 10nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718844(US20250042904, Compound 18)
Affinity DataIC50: 30nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718843(US20250042904, Compound 17)
Affinity DataIC50: 30nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718845(US20250042904, Compound 19)
Affinity DataIC50: 30nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718841(US20250042904, Compound 13)
Affinity DataIC50: 30nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718846(US20250042904, Compound 20)
Affinity DataIC50: 30nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718839(US20250042904, Compound 9)
Affinity DataIC50: 30nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM718838(US20250042904, Compound 8)
Affinity DataIC50: 30nMAssay Description:After the compound serially diluted with DMSO and a Src recombinant protein were incubated at room temperature for 10 min, the reaction was initiated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent